{
  "functional_evidence_assessment": {
    "variant_id": {
      "Gene": "EGFR",
      "Protein_Change": {
        "ref": "L858",
        "alt": "",
        "position": ""
      },
      "variant_string_id": "EGFR L858"
    },
    "functional_evidence_aim": "Pathogenic",
    "assessment_steps": [
      {
        "step_name": "Step 1: Define the disease mechanism",
        "extracted_paper_info": "The paper discusses that Parkinson's disease (PD) is characterized by protein-toxicity and Lewy bodies, which are intracytoplasmic inclusion bodies.",
        "judgment": "Yes",
        "reasoning": "The study clearly defines PD as being caused by alpha synuclein aggregation, aligning with the molecular basis of the disease."
      },
      {
        "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
        "extracted_paper_info": "The assays used include cell phenotype rescue and enzyme activity assays, which are relevant to the disease mechanism defined.",
        "judgment": "Yes",
        "reasoning": "The assays (e.g., cell toxicity) directly model PD pathogenesis."
      },
      {
        "step_name": "Step 3: Evaluate validity of specific instances of assays",
        "extracted_paper_info": "Basic controls were not explicitly mentioned, but the study did use multiple conditions with wild-type and mutant proteins.",
        "judgment": "No",
        "reasoning": "While the study tested WT and A30P variants in multiple conditions, explicit mention of variant controls is lacking."
      },
      {
        "step_name": "Step 4: Apply evidence to individual variant interpretation",
        "extracted_paper_info": "The paper did not provide statistical analyses or OddsPath values.",
        "judgment": "No statistical analysis was performed for the variants."
      },
      {
        "step_name": "Sub-step 4b: No OddsPath Calculation",
        "extracted_paper_info": "The number of total benign and pathogenic variant controls is unclear, as only two variants (WT and A30P) were tested.",
        "judgment": "Total controls are 2 (WT and A30P), which falls under â‰¤10."
      }
    ],
    "variant_controls": {
      "A30P WT (CFTR)": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "A30P mutant (EGFR)": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      }
    },
    "variant Controls Summary": {
      "Number of pathogenic variant controls used in the assay for each variant": 2,
      "Total number of variants tested in the model": 2
    }
  }
}